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In  mammals,  the  development  of  LNs  and   
Peyer’s patches (PPs) is programmed during 
ontogeny in the sterile environment of the   
fetus (Mebius, 2003). In contrast, isolated lym-
phoid follicles (ILFs) are induced to develop   
after birth in the intestinal lamina propria by 
the colonizing bacterial microbiota (Hamada   
et al., 2002; Pabst et al., 2006; Bouskra et al., 
2008). The development of both types of lym-
phoid tissues is initiated by lymphoid tissue in-
ducer (LTi) cells, which express and require the 
nuclear  hormone  receptor  RORt  for  their 
generation  (Eberl  and  Littman,  2004;  Eberl   
et al., 2004). In the fetus, LTi cells aggregate in 
LN and PP anlagen where they activate stromal 
cells through membrane-bound lymphotoxin 
(LT) 12 and LTR interaction, which results 
in the expression of adhesion molecules and 
chemokines involved in the recruitment and 
organization  of  lymphocytes  (Mebius,  2003). 
After birth, LTi cells cluster into cryptopatches 
(CPs) located between intestinal crypts. Bacte-
ria activate CPs through the shedding of pepti-
doglycans recognized by NOD-1 in epithelial 
cells and the release of -defensin-3 and CCL20 
which activate CCR6+ LTi cells and B cells 
(Bouskra et al., 2008). As a result, CPs collect   
B cells through an LTR-dependent mecha-
nism and form ILFs (Lorenz et al., 2003).
Tertiary lymphoid tissues (tLTs), which re-
semble ILFs (Eberl and Lochner, 2009), develop 
in a variety of inflammatory lesions both in 
mouse  and  man  (Aloisi  and  Pujol-Borrell, 
2006). Upon infection with influenza A virus, 
mouse lungs develop large numbers of inducible 
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The programmed development of lymph nodes and Peyer’s patches during ontogeny requires 
lymphoid tissue inducer (LTi) cells that express the nuclear hormone receptor RORt. After 
birth, LTi cells in the intestine cluster into cryptopatches, the precursors of isolated lymphoid 
follicles (ILFs), which are induced to form by symbiotic bacteria and maintain intestinal 
homeostasis. We show that in RORt-deficient mice, which lack LTi cells, programmed 
lymphoid tissues, ILFs, and Th17 cells, bacterial containment requires the generation of large 
numbers of tertiary lymphoid tissues (tLTs) through the activity of B cells. However, upon 
epithelial damage, these mice develop severe intestinal inflammation characterized by 
extensive recruitment of neutrophils and IgG+ B cells, high expression of activation-induced 
deaminase in tLTs, and wasting disease. The pathology was prevented by antibiotic treatment 
or inhibition of lymphoid tissue formation and was significantly decreased by treatment with 
intravenous immunoglobulin G (IVIG). Our data show that intestinal immunodeficiency, such 
as an absence in RORt-mediated proinflammatory immunity, can be compensated by 
increased lymphoid tissue genesis. However, this comes at a high cost for the host and can 
lead to a deregulated B cell response and aggravated inflammatory pathology.
© 2011 Lochner et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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IL-10 (McGeachy et al., 2009). Most 
persuasively, a gain-of-function mu-
tation  in  the  IL-23R  predisposes   
patients to the development of inflam-
matory  bowel  disease  (Duerr  et  al., 
2006). Th17 cells, which depend on 
RORt for their generation (Ivanov 
et  al.,  2006),  have  been  shown  to   
be  required  for  disease  development   
in an adoptive transfer model of colitis (Leppkes et al., 
2009). Furthermore, IL17R-deficient mice are resistant to 
trinitrobenzenesulfonic-induced colitis, even in the presence 
of increased levels of IL-12 and IFN- (Zhang et al., 2006). 
It is therefore suggested that antagonists of IL-17R and 
RORt could prevent colitis. However, other models of coli-
tis are associated with a Th1 type or a Th2 type of immune 
responses, which may limit the effectiveness of a therapeutic 
targeting of the IL-17/23 pathway (Uhlig and Powrie, 2009).
In this paper, we demonstrate that tLTs can be induced 
both in influenza A–infected lungs and during colitis in the 
absence of RORt and LTi cells. Instead, in the DSS model 
of mouse colitis, we show that the formation of tLTs is   
dependent on LT expressed by B cells. The lack of Th17 
cells, as well as the lack of other populations of IL-17– and 
IL-22–producing T  cells  and  innate  lymphoid  cells  in 
RORt-deficient mice (Ivanov et al., 2006; Satoh-Takayama 
et  al.,  2008;  Sanos  et  al.,  2009),  does  not  protect  mice   
from inflammatory disease. On the contrary, the absence of 
RORt+ cells to contain the intestinal microbiota is com-
pensated by the formation of a large number of tLTs that 
leads to severe inflammatory pathology upon epithelial 
damage, which is characterized by increased B cell recruit-
ment and differentiation. Disease progression is prevented by 
concomitant treatment of the mice with a broad spectrum 
antibiotic cocktail and with an antagonist to the LTR   
that blocks the formation of tLTs and is mitigated by treat-
ment  with  i.v.  IgG  (IVIG),  which inhibits B cell–induced   
bronchus-associated lymphoid tissues (iBALTs) that promote 
local immunity and memory to the virus (Moyron-Quiroz   
et al., 2004, 2006). The formation of iBALT is independent of 
RORt+ LTi cells. In that context, LTi function may be per-
formed by abundant effector lymphocytes, such as B cells, 
that are recruited to the infected lung and, similar to LTi cells, 
express LT12 (Ansel et al., 2000). In the pancreas of aged 
nonobese diabetic (NOD) mice, tLTs develop that provide a 
positive-feedback loop to local inflammation and exacerbate 
the pathology (Lee et al., 2006). The requirement for LTi cells 
in the formation of pancreatic tLTs has not been formally as-
sessed, but central to this process is the recruitment of islet 
antigen-specific T cells. In that case, the ligand activating 
LTR on stromal cells is not LT12 but LIGHT (TNFSF14). 
During intestinal inflammation induced by dextran sulfate 
sodium (DSS), a high number of tLTs are induced in mice 
that lack LNs and PPs and the disease is aggravated (Spahn   
et al., 2002). It was suggested that the pathological inflamma-
tion resulted from a failure to engage regulatory pathways in 
the absence of LNs. The role of LTi cells has not been investi-
gated in that model.
Recent studies show that the IL-17–IL-23 signaling path-
way is involved in several chronic inflammatory pathologies, 
including colitis. IL-23, a cytokine produced by DCs, mono-
cytes and macrophages (Kastelein et al., 2007) and shown to 
be essential in several experimental colitis models in mice 
(Uhlig and Powrie, 2009), promotes maturation of proinflam-
matory Th17 cells and blocks the production of regulatory 
Figure 1.  Supernumerary and mature 
tLTs induced by DSS-mediated colitis.  
(A) Quantification of tLTs in the colon of wild-
type mice before and after multiple cycles of 
DSS treatment. During each cycle, mice were 
treated with DSS for a period of 7 d, followed 
by a 10-d recovery period without DSS. Data 
are shown for one representative experiment 
out of two with three mice per group. Statis-
tical significance was assessed by the paired 
Student’s t test. *, P < 0.05. Error bars are SD. 
(B) Structure of colonic tLTs in sections of 
colons from wild-type mice after two cycles 
of DSS treatment. Sections were stained with 
the indicated antibodies and with DAPI for 
nuclear staining (shown in gray). RORt is 
visualized through GFP expression in Rorc(gt)-
GfpTG reporter mice. Bars, 200 µm.JEM VOL. 208, January 17, 2011 
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The LTi-independent formation of tLTs
Even though the generation of LTi cells and the subse-
quent development of LNs, PPs, and ILFs require expres-
sion  of  RORt  (Eberl  and  Littman,  2004;  Eberl  et  al., 
2004), tLTs induced by influenza A virus infection of the 
lungs, termed iBALT, develop normally in RORt-deficient 
mice (Moyron-Quiroz et al., 2004). In NOD mice, the 
formation of tLTs in the inflamed pancreatic islets depends 
on LIGHT expression by reactive T cells rather than LT 
(Lee et al., 2006), thus presumably in the absence of LTi 
cells. We  observed  that  RORt-deficient  mice  generated   
an  increased  number  of  mature  germinal  center–containing 
iBALTs in response to influenza A virus infection as com-
pared with infected wild-type controls (Fig. 2 A). Similarly, 
in the colon, exposure to DSS induced a threefold higher 
number of mature tLTs, as well as extensive neutrophil in-
filtration,  in  RORt-deficient  mice  as  compared  with 
control mice (Fig. 2 B and Fig. S1). Interestingly, an in-
creased number of tLTs is present already in unexposed 
RORt-deficient mice (Fig. 2 C). These data show, first, 
that tLTs can be efficiently generated in the absence of LTi 
cells during infection and inflammation and, second, that 
the  intestinal  environment  is  prone  to  spontaneous  tLT 
formation in RORt-deficient mice that lack LNs, PPs, 
ILFs,  and  several  IL-17–  and/or  IL-22–producing  lym-
phoid cells (Ivanov et al., 2006; Satoh-Takayama et al., 2008; 
Sanos et al., 2009).
inflammatory responses (Nimmerjahn  and  Ravetch,  2008). 
Our data indicate that inhibition of the Th17 pathway and 
of the normal function of lymphoid tissues may exacerbate 
inflammatory bowel disease through the generation of tLTs 
and a deregulated B cell response.
RESULTS
The formation of mature tLTs during intestinal inflammation
It was previously reported that colitis induced by 7 d of 
DSS oral treatment did not induce significant numbers of 
tLTs when compared with mice receiving water (Spahn et al., 
2002). We confirm this observation but observed a marked 
increase in the number of tLTs after a 10-d period of rest 
that followed the initial 7 d of DSS (Fig. 1 A). The number 
of tLTs increased only marginally upon a second cycle of 
DSS treatment, followed by another rest period, and re-
mained stable during subsequent cycles of treatment. These 
tLTs were significantly larger than ILFs found in untreated 
mice. Yet, like conventional ILFs (Hamada et al., 2002; Eberl 
and Littman, 2004), these structures were composed of a well 
defined B cell follicle surrounded by a shell of DCs and 
contained mostly IgM+  B  cells,  a  germinal  center,  dis-
persed LTi cells, and T cells, but no defined T cell zone 
(Fig. 1 B). Stromal cells expressed  VCAM-1, which is typical 
of  stromal  cells  found  in  lymphoid  tissues,  collectively 
termed lymphoid stromal cells (Honda et al., 2001; Peduto 
et al., 2009).
Figure 2.  tLTs form in the absence of LTi 
cells. (A) Quantification of influenza virus A–
induced iBALT. RORt/ or wild-type control 
mice were infected intranasally with 50 pfu 
influenza virus A and sacrificed 3 wk later. 
Histograms show mean numbers of lymphoid 
follicles in sections of whole lungs. Data 
shown are the mean for seven mice per group 
from two independent experiments. *, P < 0.05. 
Sections were stained with the indicated anti-
bodies. Bars, 200 µm. (B and C) Quantification 
of tLTs in the colon of RORt/ and wild-
type control mice. The number of colonic tLTs 
was assessed as described in Materials and 
methods and is indicated as the mean number 
of tLTs per whole colon section. Data shown 
for adult mice that were either treated with 
two cycles of 2.5% DSS (B) or left untreated 
(C). Figures show data compiled from 10–15 
mice per group from three independent ex-
periments. *, P < 0.001. Histology shows rep-
resentative colon samples from RORt/ or 
wild-type control mice either treated with 
two cycles of 2.5% DSS or left untreated. 
Sections were stained with anti-CD45R/B220 
antibodies to visualize tLTs and DAPI for nu-
clear staining. Single pictures of 100× magni-
fied sections were assembled to generate an 
integral view of a colon. Bars, 0.5 cm. Statisti-
cal significance was assessed by the paired 
Student’s t test. Error bars are SD.128 LTi-independent lymphoid tissues in severe colitis | Lochner et al.
tLTs in the pancreas of aged NOD mice (Lee et al., 2006).   
As tLTs generated in the colon of DSS-treated mice consist 
mostly of mature B cell follicles, we hypothesized that a subset 
of B cells expressing LT12 (Ansel et al., 2000) may function 
as LTi cells in that context. In that regard, it has been reported 
that LT12-expressing B cells, in addition to LTi cells, are 
required for the full development of ILFs (Lorenz et al., 2003). 
Bone marrow chimeras were thus generated that lacked ex-
pression of LT on T cells, on B cells, or both. In the absence 
of LT expressed by T cells, the number of tLTs induced   
during colitis was similar to the number of tLTs induced in 
unmanipulated wild-type mice (Fig. 3 C). In contrast, in the 
absence of LT expressed by B cells, or both B and T cells, the 
number of tLTs dropped to the number of tLTs generated in 
the absence of colitis. Thus, DSS-mediated colitis induces the 
formation of tLTs through the LTi function of LT12- 
expressing B cells. Nevertheless, it remains formally possible 
that LT12-expressing cells types, in addition to lympho-
cytes, are involved in the formation of tLTs during DSS- 
mediated colitis in the absence of LTi cells, although no such 
cells have been identified yet.
Containment of microbiota in the absence of RORt+ cells
Despite the absence of LTi cells, RORt-deficient mice de-
velop significantly higher numbers of mature intestinal tLTs, 
both during steady state and exposure to DSS (Fig. 2, B   
and C). As DSS-mediated colitis is dependent on microbiota 
(Hans et al., 2000) and RORt-deficient mice lack lymphoid 
tissues and cells involved in intestinal homeostasis and defense 
(Eberl and Littman, 2004; Eberl et al., 2004; Ivanov et al., 
2006; Satoh-Takayama et al., 2008; Eberl and Lochner, 2009; 
Sanos et al., 2009), we assessed whether microbiota was   
responsible for the increased lymphoid tissue genesis. In 
RORt-deficient mice treated with a large-spectrum cocktail 
of antibiotics during exposure to DSS, induction of tLTs was ab-
rogated (Fig. 4 A). The induction of tLTs was also abrogated 
in  antibiotic-treated  RORt-deficient  mice  during  steady 
state. In contrast, antibiotics had no visible effect on the gen-
eration of lymphoid tissues in the colon of wild-type mice 
during steady state, indicating that several of these colonic 
lymphoid tissues are LTi cell dependent and programmed 
lymphoid tissues, such as colonic patches (Eberl and Lochner, 
2009) and, thus, not tLTs.
We next assessed whether the microbiota-induced forma-
tion of tLTs in RORt-deficient mice was a consequence of 
decreased containment of the intestinal microbiota. It was re-
cently reported that mice deficient in both Myd88 and TRIF, 
which are involved in the signaling of toll-like receptors, 
show deficient containment of the microbiota (Slack et al., 
2009). As a consequence, an increased number of live bacteria 
was recovered from the spleen, and microbiota-specific IgG 
was detected in the serum. Although exposure to DSS increased 
the number of live bacteria found in the spleen, no significant 
difference was observed between RORt-deficient mice and 
wild-type controls during steady state and colitis (Fig. 4 B).   
In contrast, markedly higher titers of serum IgG directed 
An LTi function for B cells
We first assessed whether tLTs generated during DSS-mediated 
colitis were induced through the canonical LTR pathway.   
In both LTR-deficient mice and RORt-deficient mice 
treated with LTR-Ig fusion protein, the induction of tLTs 
during DSS-mediated colitis was markedly inhibited (Fig. 3, 
A and B). LTR has two known ligands, LT12 and LIGHT 
(Gommerman and Browning, 2003). Whereas LT12 is re-
quired for the LTi-mediated generation of LNs, PPs, and ILFs 
(Hamada et al., 2002; Mebius, 2003; Eberl and Littman, 2004), 
LIGHT is involved in the T cell–mediated generation of 
Figure 3.  The LTi function of B cells. (A) Quantification of tLTs in  
the colons of LTR-deficient and wild-type control mice that were either 
untreated or treated with two cycles of 2.5% DSS. Data are shown for  
one representative experiment out of two with three mice per group.  
(B) Quantification of colonic tLTs in RORt/ mice that were treated with 
two cycles of 2.5% DSS and by weekly i.p. injections of LTR-Ig fusion 
protein or control Ig. Data are shown for one representative experiment 
out of two with six mice per group. *, P < 0.005. (C) Quantification of tLTs 
in the colon of wild-type mice and mixed bone marrow chimeras after 
two cycles with 2% DSS. For mixed bone marrow chimeras, irradiated 
adult C57BL/6 wild-type mice received bone marrow from LT/ mice 
that was mixed 1:1 with bone marrow from M/, CD3/, or RAG/ 
mice to create mice that lack LT expression in B cells, T cells, or both  
B and T cells. DSS treatment was initiated 6 wk after transfer. Data are 
shown for one representative experiment out of three with five mice per 
group. *, P < 0.001. Statistical significance was assessed by the paired 
Student’s t test. Error bars are SD.JEM VOL. 208, January 17, 2011 
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mice was prevented 
by  the  administra-
tion  of  antibiotics, 
as expected, as well 
as  by  blocking  the 
formation of tLTs with LTR-Ig fusion protein (Fig. 5, C and 
D; and Fig. S2; Rennert et al., 1998). These data demonstrate 
that the supernumerary intestinal tLTs exacerbate the inflam-
matory pathology caused by the intestinal microbiota in DSS-
treated RORt-deficient mice.
Furthermore, in the absence of RORt required for the 
generation of several IL-17– and/or IL-22–producing lym-
phoid cells (Ivanov et al., 2006; Satoh-Takayama et al., 2008; 
Sanos et al., 2009), the intestinal immune response to DSS 
shifted from a Th17 type of response to a IFN-–dominated 
Th1 type of response (Fig. 5 E, Fig. S3 A, and Fig. S4). How-
ever, neutralization of IFN- in DSS-treated RORt-deficient 
mice did not protect from severe colitis (Fig. 5 F) and had   
no impact on the number of tLTs (Fig. S3B). In contrast, 
complementation of RORt-deficient mice with RORt-
sufficient spleen cells, but not RORt-deficient cells, partially 
protected from colitis (Fig. S5), indicating that RORt+ cells 
contribute to protection from pathology and thus are involved 
in intestinal homeostasis. Together, these data show that in the 
absence of RORt+ cells, including Th17 cells and lymphoid 
tissues induced by RORt+ LTi cells, mice develop aggravated 
colitis induced by microbiota and supernumerary tLTs.
against bacterial microbiota were found in RORt-deficient 
mice at steady state, a difference which nevertheless vanished 
during colitis (Fig. 4 C). Thus, although wild-type mice can 
contain microbiota during steady state without the formation 
of large numbers of intestinal tLTs and increased serum IgG, 
RORt-deficient mice need to increase the number of intes-
tinal tLTs and the production of systemic microbiota-specific 
IgG to reach a similar levels of containment. Furthermore, upon 
epithelial damage, RORt-deficient mice required even larger 
numbers of intestinal tLTs to be able to develop a level of con-
tainment comparable to that of wild-type mice. In that context, 
the bacterial microbiota was not significantly different between 
wild-type and RORt-deficient mice (Fig. 4 D), indicating 
that RORt-deficient mice were still able to develop a level of 
selective pressure on the microbiota that was comparable to the 
selective pressure developed by wild-type mice.
Supernumerary tLTs exacerbate colonic pathology
Even  though  an  increased  number  of  intestinal  tLTs  may 
compensate for the immunodeficiencies of RORt-deficient 
mice, at least for the containment of the intestinal microbiota, 
this comes at a high cost for the organism. When exposed   
to DSS,  and  in  our  experimental  conditions  (Fig.  1 A), 
RORt-deficient  mice  developed  severe colitis (Fig. 5 A)   
and  wasting  disease  (Fig.  5  B),  whereas  wild-type  mice   
developed a mild colitis and no wasting disease. The severe 
colitis and wasting disease developing in RORt-deficient 
Figure 4.  Containment of microbiota in 
the absence of RORt+ cells. (A) RORt/ 
and wild-type control mice were treated from 
birth with a cocktail of antibiotics. 8-wk-old 
mice were exposed or not to two cycles of 
DSS before quantification of tLTs. Data are 
shown for one representative experiment out 
of two with five mice per group. *, P < 0.0001. 
Statistical significance was assessed by the 
paired Student’s t test. n.s., not significant; 
Abx, antibiotic treated. (B) The bacterial con-
tent in the spleen of RORt/ and wild-type 
control mice was determined by plating 
spleen extracts from three individual mice 
exposed or not to DSS on blood agar plates. 
CFU, colony forming unit. Data are shown for 
one representative experiment out of two.  
(C) The IgG response specific for intestinal 
bacteria was determined in the sera from the 
peripheral blood of RORt/ and wild-type 
control mice exposed or not to DSS. Data 
from one representative experiment out of 
three and three mice per group show the 
percentage of bacteria positive for IgG bind-
ing. *, P < 0.05. As a baseline control, bacteria 
were directly stained with anti–mouse IgG 
without the addition of serum (not depicted). 
(D) Colon biofilms were collected from 8-wk-
old RORt/ and wild-type control mice and 
the bacterial content was determined by 
quantitative PCR. Data are shown for one 
representative experiment out of two with 
five mice per group. SFB, segmented filamen-
tous bacteria; Lactob, Lactobacillaceae; Clostr, 
Clostridiales; Bact, Bacteroides; Enterob,  
Enterobacteriaceae. Error bars are SD.130 LTi-independent lymphoid tissues in severe colitis | Lochner et al.
DISCUSSION
tLTs form within numerous types of chronic inflammatory 
lesions (Aloisi and Pujol-Borrell, 2006) and have been shown 
to function like secondary lymphoid tissues in the induction 
of effector B and T cells (Lee et al., 2006; Moyron-Quiroz   
et al., 2006; Nasr et al., 2007). These inducible tissues can 
provide protection to virus infection in the absence of LNs 
or aggravate inflammatory disease. Therefore, in the latter 
context, it has been suggested that the formation of tLTs may 
be blocked as a strategy to prevent or mitigate inflammatory 
disease. The development of LNs and PPs in the fetus (Eberl 
et al., 2004), and of ILFs in the intestinal lamina propria   
(Eberl and Littman, 2004), requires RORt+ LTi cells, and in 
the absence of RORt, these lymphoid tissues do not de-
velop. RORt is also required to generate the proinflamma-
tory Th17 cells (Ivanov et al., 2006) and IL-22–producing 
NKp46+ innate lymphoid cells (Satoh-Takayama et al., 2008; 
Luci et al., 2009). Thus, it has been suggested that RORt 
antagonists may be developed to block excessive immunity 
and chronic inflammation in several pathological settings. 
However, the role of RORt+ LTi cells in the formation of 
tLTs during inflammation remained to be clearly assessed, 
and the effect of an absence of functional RORt, which is 
involved in the generation of both lymphoid tissues and 
Th17 cells, must be carefully measured during inflamma-
tory disease.
Hyperactive tLTs and B cells as a cause of aggravated 
colonic pathology
Intestinal tLTs, as ILFs, are primarily B cell follicles harboring 
a germinal center but no distinct T cell zone (Fig. 1 B; Eberl 
and Lochner, 2009). We therefore tested whether tLTs aggra-
vate colonic pathology in DSS-treated RORt-deficient 
mice by inducing a hyperactive B cell compartment. In ac-
cordance with this view, tLTs in such mice express a 30-fold 
increase in transcripts for the activation-induced deaminase 
AID (Fig. 6 A), which is required for gene switch recombina-
tion  and  somatic  hypermutation  of  Ig  genes  (Muramatsu   
et al., 2000). Possibly as a consequence, even though it is dif-
ficult to assess, IgG+ B cells were present in the lamina propria 
of DSS-treated RORt-deficient mice but not in wild-type 
mice (Fig. 6 B). To demonstrate that Igs were involved in the 
pathology induced by tLTs, we treated RORt-deficient 
mice concomitantly with DSS and IVIG, which have a thera-
peutic effect against a broad range of hematological and im-
munological disorders, essentially through the saturation and 
activation of Fc receptors (Nimmerjahn and Ravetch, 2008). 
IVIG treatment significantly decreased the colonic pathol-
ogy induced by tLTs in RORt-deficient mice (Fig. 6 C).   
Together, our data indicate that in the absence of RORt, the 
supernumerary tLTs induced by the microbiota are nurturing 
a hyperactive B cell compartment that contributes to the ag-
gravated colonic pathology.
Figure 5.  tLTs aggravate DSS-mediated 
colitis. (A) Histological disease score in 
RORt/ and wild-type control mice exposed 
to two cycles of DSS. Scores are shown for 
eight mice per group from three independent 
experiments. *, P < 0.01. H&E staining of rep-
resentative sections from distal colon of 
RORt/ and wild-type control mice after 
exposure to two cycles of DSS is shown. Bars, 
200 µm. (B) Wasting disease. RORt/ and 
wild-type control mice were exposed to DSS 
cycles as indicated, and mouse body weight 
was assessed at the beginning of every cycle. 
Shown are weights relative to the starting 
weight. Data derive from eight mice per  
group from three independent experiments.  
*, P < 0.01. (C and D) LTR blockade ameliorates 
DSS colitis. Wild-type and RORt-deficient 
mice were exposed to two cycles of DSS. 
RORt/ mice were either treated by weekly 
i.p. injections of LTR-Ig protein or with a 
control Ig. One group of RORt/ mice was 
treated from birth with a cocktail of antibiot-
ics. Data are shown for six mice per group 
from two to three independent experiments.  
*, P < 0.01. Shown is mouse weight at the end 
of the second DSS cycle in percentage of the 
starting weight (C) and histological disease score (D). Abx, antibiotic treated. (E) Quantitative real-time PCR on whole colon tissue from untreated wild-
type controls and RORt/, as well as wild-type control mice after exposure to DSS. Ct values were normalized to Gapdh expression. Data shown are for 
one representative experiment out of three with two mice per group. *, P < 0.05. (F) RORt/ mice were treated with two i.p. injections of 250 µg of 
neutralizing anti–IFN- antibody before the first and the second DSS cycle. Data are shown for one representative experiment out of two with three mice 
per group. ns, not specific. P > 0.05. Statistical significance was assessed by the paired Student’s t test. Error bars are SD.JEM VOL. 208, January 17, 2011 
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We show that the formation of tLTs in RORt-deficient 
mice is induced by microbiota through the LTi function of   
B cells, even though we do not formally exclude an LTi func-
tion for other cell types in that context. So how does micro-
biota induce the recruitment of LT+ B cells? We had shown 
previously that CCL20 was required for the recruitment of   
B cells and the formation of ILFs (Bouskra et al., 2008) but 
expression of CCL20 was undetectable in RORt-deficient 
mice. The only cytokine found to be increased in RORt-
deficient mice treated with DSS was IFN-; however, block-
ing IFN- with neutralizing antibody had no effect on the 
number of tLTs and the severity of disease. The intestine of 
DSS-treated RORt-deficient mice nevertheless showed an 
important infiltration of IgG+ B cells. We therefore suggest 
that the microbiota-induced inflammation unfolding in DSS-
treated RORt-deficient mice eventually leads to the sustained 
recruitment of B cells, which induce the formation of tLTs 
through their expression of LT12. Given that tLTs are pri-
marily B cell follicles, this pathway can generate a positive-
feedback loop in B cell activation and differentiation and in 
the formation of tLTs.
In RORt-deficient mice during steady state or that 
have been exposed to DSS, a vast network of tLTs develops 
that contains approximately three times the number of tLTs 
found in wild-type mice subjected to the same treatments. 
RORt is required for the development of LNs and PPs, as 
well as for the generation of a collection of lymphoid cells 
producing IL-17 and/or IL-22, such as Th17 cells and IL-22+ 
NKp46+ cells. The latter cell type was recently shown to be 
involved in protection against infection by Citrobacter roden-
tium and DSS-induced colitis (Satoh-Takayama et al., 2008), 
and IL-17 and IL-22 synergize in the activation of epithelial 
cells to produce antibacterial peptides (Liang et al., 2006). 
Thus, it might be expected that the absence of lymphoid tis-
sues and of IL-17/22–producing lymphoid cells in RORt-
deficient will be matched by the increased activity in other 
immune compartments, such as tLT formation, to maintain 
a similar level of containment of the intestinal microbiota. 
Such a compensatory mechanism has been reported by Lorenz 
et al. (2003); the inhibition of development of secondary 
lymphoid tissues through the administration of LTR-Ig pro-
tein to pregnant mothers induced the formation of numer-
ous tLTs or ILFs. However, when exposed to DSS, which 
injures the epithelial cell layer, RORt-deficient mice ap-
pear only to be able to contain microbiota at the price of 
an additional increase in intestinal tLTs and B cell activity. 
This increase in the number of tLTs and in B cell activity is, 
however,  not  tolerated  by  the  intestine,  which  develops   
severe inflammation and leads the host to wasting disease. 
This pathology is possibly a consequence of the formation 
of immune complexes consisting of bacteria and specific 
IgG,  which  activate  IgG  receptor-bearing  inflammatory 
cells, such as neutrophils. This hypothesis is supported by 
the  antiinflammatory  effect  of  IVIG  treatment,  which   
is shown to depend on IgG receptors (Nimmerjahn and   
Ravetch, 2008).
We find that during colitis induced by DSS, mature colonic 
tLTs develop that consist of a well structured B cell follicle con-
taining  predominantly  IgM+  B  cells  and  a  germinal  center.   
Similar tLTs termed iBALTs were reported in influenza A– 
infected lungs (Moyron-Quiroz et al., 2004). In the absence of 
LTi cells in RORt-deficient mice, both iBALT and colonic 
tLTs develop, indicating that other cells can take over the func-
tion of LTi cells for the induction of lymphoid tissues. In the 
case of tLTs induced in the pancreas of aged NOD mice, the 
LTi function is taken over by autoreactive T cells (Lee et al., 
2006). Central to the development of LNs, PPs, and ILFs   
is LTR-mediated activation of stromal cells by LT12- 
expressing LTi cells (Mebius, 2003). Activated stromal cells 
produce the structural chemokines CC19, CCL21, and CXCL13, 
which are involved in the recruitment and organization of lym-
phocytes and DCs (Dejardin et al., 2002). In the inflamed pan-
creas,  T cells induce the formation of tLTs through the alternative 
LTR ligand LIGHT (Lee et al., 2006).  The formation of iBALTs 
is independent of LT (Moyron-Quiroz et al., 2004), and the 
involvement of LIGHT remains to be assessed. In the case of 
DSS-induced colonic tLTs, B cells perform the LTi function 
through  LT,  and  thus,  presumably,  through  its  membrane-
bound LT12 heterotrimer. Together, these data show that   
tLTs can develop during chronic inflammation through similar 
mechanisms but distinct lymphocyte or lymphoid cell subsets.
Figure 6.  Hyperactive tLTs and B cells as a cause of aggravated 
colonic pathology. RORt/ and wild-type control mice were treated 
with two cycles of 2.5% DSS. (A) The expression of AID was assessed by 
quantitative RT-PCR in laser-captured tLTs from DSS-treated RORt/ 
and wild-type control mice. Data are shown for one representative experi-
ment out of two with two mice per group. Ct values were normalized to 
Gapdh expression. (B) Colon sections were stained for IgG, B220, and 
DAPI for nuclear staining (shown in gray). IgG+ B plasma cells express low 
levels of B220. Bars, 200 µm. Data are shown for one representative ex-
periment out of two with three mice per group. (C) RORt/ mice were 
treated with two i.p. injections of IVIG. The histological disease score was 
assessed as described in Materials and methods. Data are shown for one 
representative experiment out of two with two to three mice per group. 
Statistical significance was assessed by the paired Student’s t test.  
*, P < 0.05. Error bars are SD.132 LTi-independent lymphoid tissues in severe colitis | Lochner et al.
40 sections of a whole colon were taken at regular intervals and fixed for 5 min 
in acetone at 20°C. For staining, slides were first hydrated in PBS-BS (PBS 
containing 1% normal bovine serum; Sigma-Aldrich) for 5 min and blocked 
with 10% bovine serum in PBS for 1 h at room temperature. Slides were then 
incubated  with  anti-phycoerythrin–conjugated  anti-CD45R/B220  mAb 
(clone RA3-6B2) in PBS-BS at room temperature for 1 h, washed three 
times for 5 min with PBS-BS, incubated with DAPI (Sigma-Aldrich) for   
5 min at room temperature, washed three times for 5 min, and mounted with 
Fluoromount-G  (SouthernBiotech).  Numbers  of  tLTs  per  colon  section 
were calculated as the mean number of tLTs per section in 40 sections.
Influenza virus A infection. Mice were infected intranasally with 50 PFU 
influenza A virus (H3N2 strain Scotland/20/74). Mice were sacrificed 21 d 
after infection.
Immunofluorescence histology. For immunofluorescence histology, tis-
sues were fixed and stained as previously described (Peduto et al., 2009).   
In brief, tissues were washed and fixed overnight at 4°C in a fresh solution   
of 4% paraformaldehyde (Sigma-Aldrich) in PBS. The samples were then 
washed for 1 d in PBS, incubated in a solution of 30% sucrose (Sigma- 
Aldrich) in PBS, and embedded in OCT. Frozen blocks were cut at 8-µm 
thickness  and  sections  collected  onto  Superfrost  Plus  slides  (VWR).  For 
staining, slides were first hydrated in PBS-XG (PBS containing 0.1% Triton 
X-100 and 1% normal goat serum; Sigma-Aldrich) for 5 min and blocked 
with 10% bovine serum in PBS-XG for 1 h at room temperature. Slides were 
then incubated with primary polyclonal antibody or conjugated mAb (in 
general 1/100) in PBS-XG overnight at 4°C, washed three times for 5 min 
with PBS-XG, incubated with DAPI for 5 min at room temperature, washed 
three times for 5 min, and mounted with Fluoromount-G. Slides were exam-
ined under a fluorescence microscope (AxioImager M1; Carl Zeiss, Inc.) 
equipped with a charge-coupled device camera and images were processed 
with AxioVision software (Carl Zeiss, Inc.).
Laser capture microdissection. Colon tissues were embedded in OCT 
compound 4583 (Sakura), frozen in a bath of isopentane cooled with liquid 
nitrogen, and stocked at 80°C. Frozen blocks were cut at 10-µm thickness 
and serial sections collected onto Superfrost/Plus slides. Sections were im-
mediately fixed for 5 min in acetone at 20°C, dried, and stored at 80°C. 
Serial sections were then thawed and immediately stained for 5 s with histo-
gen (MDS Analytical Technologies), washed briefly in RNase-free water 
supplemented with ProtectRNA (Sigma-Aldrich), dehydrated successively 
in one bath of 70% ethanol for 30 s, two baths of 95% ethanol for 1 min, two 
baths of water-free ethanol (VWR) for 2 min, and two baths of xylene for   
5 min, and air-dried. Slides were transferred immediately into a Veritas Laser 
Capture Microdissector (MDS Analytical Technologies), microdissected, and 
captured with Capsure Macro LCM caps (MDS Analytical Technologies). 
RNA was isolated using the PicoPure RNA Isolation kit (MDS Analytical 
Technologies), and its quality was assessed using the 2100 Bioanalyzer system 
(Agilent Technologies).
Antibodies. The following mAbs were purchased from BD: PE-conjugated 
anti–mouse IgM (R6-60.2); from eBioscience: allophycocyanin-conjugated 
anti-CD45R/B220  (RA3-6B2),  PE-conjugated  anti-CD106  (VCAM-1; 
429), anti-CD11c (N418), anti-IgA (11–44-2), biotinylated anti–Ly-77 
(GL7), and purified anti-CD3 (500A2); and from Serotec: biotinylated anti-
neutrophil (7/4). Cy3-anti–armenian or –syrian hamster and DyLight   
488  donkey  anti–mouse  IgG  were  purchased  from  Jackson  Immuno-
Research Laboratories. Cy3-conjugated streptavidin was purchased from 
Sigma-Aldrich.
Colitis disease score. Swiss rolls of whole colons were directly frozen in 
OCT and sections of 7-µm thickness were stained with hematoxylin and   
eosin (H&E). Histological scoring was performed using a modified scoring 
system described previously (Hartmann et al., 2000). In brief, the presence of 
rare inflammatory cells in the lamina propria were counted as: 0, increased num-
bers of inflammatory cells; 1, confluence of inflammatory cells; 2, extending 
RORt  controls  the  proinflammatory  IL-17  pathway 
(Ivanov et al., 2006), which is shown to be involved in auto-
immune pathology through the recruitment of neutrophils 
(Weaver et al., 2006). The IL-17/23 pathway is involved in 
several colitis models in mice (Uhlig and Powrie, 2009), and 
patients with a defective IL-23R show resistance to the devel-
opment of the disease (Duerr et al., 2006). Therefore, it can be 
expected that the absence of RORt, or antagonizing RORt 
function during the initial phase of inflammation, protects 
from progression to inflammatory disease. We show that coli-
tis induced by exposure to DSS was actually more severe in 
RORt-deficient mice as compared with RORt-sufficient 
mice. In the absence of RORt, the colon developed pro-
found tissue damage, and mice suffered from marked wasting 
disease, whereas in the presence of RORt, mice endured 
mild intestinal inflammation under the regimen applied and 
grew normally. Furthermore, complementation of RORt-
deficient  mice  with  RORt-sufficient  spleen  cells  signifi-
cantly decreased the severity of the disease, demonstrating a 
protective effect of RORt+ cells in intestinal pathology. We 
suggest that RORt+ cells, including Th17 cells and IL-22–
producing  NKp46+  cells,  limit  DSS-induced  intestinal  in-
flammatory disease by strengthening antibacterial immunity, 
such as the production of antibacterial peptides by epithelial 
cells (Liang et al., 2006). Thus, our data show that a narrow 
road has to be followed to prevent the pathological effect of 
immunity during colitis while maintaining the essential func-
tions of immunity for intestinal homeostasis and defense.
MATERIALs And METHOds
Mice. RORt-deficient (Rorc(t)Gfp/Gfp) mice (Eberl et al., 2004) and BAC 
transgenic Rorc(gt)-GfpTG mice (Lochner et al., 2008) have been described 
previously. Mice deficient in LTR (Fütterer et al., 1998), LT (Alimzhanov 
et al., 1997), mu chain (Kitamura et al., 1991), CD3 epsilon (Malissen et al., 
1995), and RAG2 (Shinkai et al., 1992) have been described before. All mice 
were kept in specific pathogen-free conditions and all animal experiments 
were approved by the committee on animal experimentation of the Institut 
Pasteur and by the French Ministry of Agriculture.
In  vivo  treatments.  For  antibiotic  treatment,  pregnant  mothers  were 
treated with a mixture of 1 mg/ml ampicillin, 1 mg/ml colistin, and 5 mg/ml 
streptomycin together with 5% glucose (all from Sigma-Aldrich) in their 
drinking  water. After  birth,  treatment  was  continued  until  analysis.  For 
LTR-Ig treatment, mice were treated with LTR-Ig fusion protein (gift 
from J. Browning, Biogen Idec, Cambridge, MA; Browning et al., 1997) by 
weekly i.p. injections of 10 µg/mg of body weight during the course of the 
experiment. Control mice were treated with the Ig fusion partner. For IFN- 
neutralization, mice received two i.p. injections of 250 µg of neutralizing 
anti–IFN- (clone R4-6A2; eBioscience) or isotype control antibodies before 
the first and second DSS cycle. Colitis was induced using DSS salt (mol wt = 
36,000–50,000; MP Biomedicals) dissolved in the drinking water at a con-
centration of 2.5% (m/v). Mice were exposed to DSS for 7 d, followed by a 
recovery period of 10 d without DSS. This cycle was repeated once or twice 
and weight was monitored at the end of every cycle. For IVIG treatment, 
DSS-treated mice received two i.v. injections of Gamunex 10% (Talecris 
Biotherapeutics) at a concentration of 1 g/kg at the end of a first DSS cycle 
(day 5) and 1 d before a second DSS cycle (day 11).
Quantification of tLTs. Whole colons were frozen as swiss rolls in OCT 
compound  4583  (Sakura)  and  frozen  blocks  were  cut  as  7-µm  sections.   JEM VOL. 208, January 17, 2011 
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on Brucella agar plates containing 5% horse blood. Colonies were counted 
after 2 d of culture at 37°C.
Online supplemental material. Fig. S1 shows the structure of tLTs and 
neutrophil recruitment in DSS-treated RORt-deficient mice. Fig. S2 shows 
the histology of the effect of LTR-Ig and antibiotics on colitis progression. 
Fig. S3 shows the increased expression of IFN- by CD4+ T cells and the 
lack of impact of neutralizing IFN- in disease severity. Fig. S4 shows the 
expression of transcripts for LIGHT, LT, LT, and LTR in colonic tissue. 
Fig. S5 shows the effect of RORt-sufficient spleen cells upon transfer into 
irradiated RORt-deficient mice. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20100052/DC1.
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